UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

Form 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2019

Commission File Number 1-14840

 

 

AMDOCS LIMITED

 

 

Hirzel House, Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F  ☒                FORM 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

YES  ☐                NO  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _______

 

 

 


On November 12, 2019, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended September 30, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

AMDOCS LIMITED

By:

 

/s/ Matthew E. Smith

 

Matthew E. Smith

 

Secretary and Authorized Signatory

Date: November 12, 2019


EXHIBIT INDEX

 

EXHIBIT NO.

  

DESCRIPTION

99.1    Amdocs Limited Press Release dated November 12, 2019.
EX-99.1

Exhibit 99.1

 

 

Amdocs Limited Reports Fourth Quarter Fiscal 2019 Results

Record Quarterly Revenue of $1.03 Billion

Expects Fiscal 2020 Revenue Growth of 2.0%-6.0% YoY in Constant Currency

Signs Strategic Multi-Year Managed Services Agreement with AT&T

Quarterly Cash Dividend to be Raised From $0.285 to $0.3275 Per Share

Fourth Quarter Fiscal 2019 Highlights

 

   

Revenue of $1,030 million, at the midpoint of the $1,015-$1,055 million guidance range, adjusting for a negative impact from foreign currency movements of approximately $5 million compared to our guidance assumptions

 

   

GAAP diluted EPS of $0.90, above the $0.81-$0.89 guidance range

 

   

Non-GAAP diluted EPS of $1.08, above the midpoint of the $1.04-$1.10 guidance range

 

   

GAAP operating income of $144 million; GAAP operating margin of 14.0%

 

   

Non-GAAP operating income of $178 million; non-GAAP operating margin of 17.3%

 

   

Quarterly free cash flow of $179 million, comprised of cash flow from operations of $214 million, less $34 million in net capital expenditures and other; normalized free cash flow of $190 million (1)

 

   

Twelve-month backlog of $3.49 billion, up $90 million sequentially and up 3.9% as compared to last year’s fourth fiscal quarter

 

   

The board of directors approved a quarterly cash dividend of $0.285 per share to be paid on January 24, 2020

 

   

The board of directors also approved a 15% increase in the Company’s quarterly cash dividend payment from $0.285 per share to $0.3275 per share, anticipated to be first paid in April 2020, subject to shareholder approval at the January 2020 annual meeting

 

 

(1)    Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding).


   

The board of directors has approved a share repurchase plan authorizing the repurchase of up to $800 million of ordinary shares at the company’s discretion; this plan has no expiration date and is in addition to the current authorization, which, as of September 30, 2019, provided for up to $239 million of remaining repurchase authority

ST. LOUIS – November 12, 2019 – Amdocs Limited (NASDAQ: DOX) today reported operating results for the three months ended September 30, 2019.

“We are pleased to report a strong finish to our fiscal year 2019. Q4 revenue was in line with the midpoint of our guidance on a constant currency basis and was driven by stable trends in North America, solid year-over-year growth in Rest of World and our best quarter in more than a decade in Europe. Profitability was stable and cash collections were healthy as we met key milestones relating to our customer project activity. As such, we exceeded our fiscal 2019 target for normalized free cash flow of $600 million and delivered full year non-GAAP earnings per share growth of 6.9%, which is consistent with the high end of the original guidance range of 3% to 7% that we provided last November,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

Sheffer continued, “Today, we are excited to announce a multi-year agreement that extends our collaboration with AT&T to modernize and upgrade AT&T’s digital business support systems, as 5G and the cloud will lead to new business and consumer applications. In addition to customer experience and digital enablement programs, our alliance with AT&T will be expanded to include activities in strategic areas such as data analytics and security. We are very proud of our deep relationship spanning many decades with AT&T and we look forward to strengthening this relationship as the communications and media industry continues to innovate at an unprecedented pace.”

Sheffer concluded, “We begin fiscal 2020 with record 12-month backlog, which is up roughly 4% from a year ago, and we have further improved our strong visibility in the first quarter with the signing of a large IT transformation project at Vodafone Germany. Overall, we expect to deliver full year non-GAAP diluted earnings per share growth of 3.0% to 7.0%


in fiscal 2020. Moreover, we plan to further enhance the total return we provide to shareholders by raising our quarterly dividend for the seventh consecutive year, subject to shareholders approval at the annual meeting in January 2020”.

Revenue

Revenue for the fourth fiscal quarter ended September 30, 2019 was $1,030 million, up $5 million sequentially from the third fiscal quarter of 2019 and up 2.8% as reported and 3.6% in constant currency as compared to last year’s fourth fiscal quarter. Revenue for the fourth fiscal quarter of 2019 includes a negative impact from foreign currency movements of approximately $3 million relative to the third quarter of fiscal 2019. Revenue was at the midpoint of Amdocs’ guidance, adjusting for the negative impact of approximately $5 million of foreign currency movements relative to guidance.

Revenue for the fiscal year ended September 30, 2019, was $4.1 billion, up 2.8% from the last fiscal year and within Amdocs’ guidance range for growth of 2.4% to 3.4% year-over-year as reported. Adjusting for the negative impact of foreign currency movements, revenue was up 4.1% from the last fiscal year and within Amdocs’ guidance range for growth of 3.6% to 4.6% year-over-year.

Net Income and Earnings Per Share

The Company’s GAAP net income for the fourth quarter of fiscal 2019 was $122.0 million, or $0.90 per diluted share, compared to GAAP net income of $44.3 million, or $0.31 per diluted share, in the prior fiscal year’s fourth quarter. Net income on a non-GAAP basis was $147.1 million, or $1.08 per diluted share, compared to non-GAAP net income of $140.2 million, or $0.99 per diluted share, in the fourth quarter of fiscal 2018. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based compensation expenses, and other, net of related tax effects, in the fourth quarter of fiscal 2019, and amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, equity-based


compensation expenses, and non-recurring charges, net of related tax effects, in the fourth quarter of fiscal 2018.

The Company’s GAAP net income in fiscal 2019 was $479.4 million, or $3.47 per diluted share, compared to GAAP net income of $354.4 million, or $2.47 per diluted share, in fiscal 2018. Fiscal 2019 net income on a non-GAAP basis was $595.1 million, or $4.31 per diluted share, compared to non-GAAP net income of $579.6 million, or $4.03 per diluted share, in fiscal 2018.

For further details of reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.

Returning Cash to Shareholders

 

   

Quarterly Cash Dividend Program: On November 12, 2019, the Board approved the Company’s next quarterly cash dividend payment of $0.285 per share and set December 31, 2019 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 24, 2020. The Board also approved a 15% increase in the Company’s quarterly cash dividend payment to $0.3275 per share, which is anticipated to be first paid in April 2020, provided that the increase is approved by shareholders at the January 2020 annual general meeting of shareholders.

 

   

Share Repurchase Activity: Repurchased $90 million of ordinary shares during the fourth quarter of fiscal 2019. The board of directors has approved a share repurchase plan authorizing the repurchase of up to $800 million of ordinary shares at the company’s discretion; this plan has no expiration date and is in addition to the current authorization, which, as of September 30, 2019, provided for up to $239 million of remaining repurchase authority.

Twelve-month Backlog

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-


going support activities, was $3.49 billion at the end of the fourth quarter of fiscal 2019, up $90 million from the end of the prior quarter.

First Quarter Fiscal 2020 Outlook

 

   

Revenue of approximately $1,015-$1,055 million, assuming approximately $1 million sequential negative impact from foreign currency fluctuations as compared to the fourth quarter of fiscal 2019, including a full quarter revenue contribution from the acquisition of TTS Wireless which closed in early August

 

   

GAAP diluted EPS of approximately $0.79-$0.87. The impact of the acquisition of TTS Wireless on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation

 

   

Non-GAAP diluted EPS of approximately $1.02-$1.08, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.06-$0.08 per share of equity-based compensation expense, net of related tax effects. The impact of the acquisition of TTS Wireless on Amdocs’ non-GAAP diluted earnings per share is expected to be neutral in the first quarter of fiscal 2020

Full Year Fiscal 2020 Outlook

 

   

Revenue growth of 1.5%-5.5% year-over-year as reported

 

   

Revenue growth of 2.0%-6.0% year-over-year on a constant currency basis

 

   

Full year fiscal 2020 revenue guidance incorporates just over 1% of growth from the acquisition of TTS Wireless, and an expected negative impact from foreign currency fluctuations of about 0.5% year-over-year

 

   

GAAP diluted earnings per share growth of roughly 5.0%-12.0% year-over-year. The impact of the acquisition of TTS Wireless on GAAP diluted EPS will not be known until after Amdocs completes the purchase price allocation

 

   

Non-GAAP diluted earnings per share growth of roughly 3.0%-7.0% year-over-year, excluding amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisitions related liabilities measured at fair value, and approximately $0.24-$0.32 per share of equity-based compensation expense, net of


 

related tax effects. The impact of the acquisition of TTS Wireless on Amdocs’ non-GAAP diluted earnings per share is expected to be neutral in fiscal year 2020

 

   

Free cash flow of approximately $350 million, comprised of cash flow from operations, less net capital expenditures and other, and normalized free cash flow of approximately $480 million

Our first fiscal quarter 2020 and full year fiscal 2020 outlook takes into consideration the Company’s expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, Amdocs notes market dynamics continue to shift rapidly and that it cannot predict all possible outcomes, including those resulting from T-Mobile’s proposed merger with Sprint, or from other current and potential customer consolidation activity.

Conference Call Details

Amdocs will host a conference call on November 12, 2019 at 5:00 p.m. Eastern Time to discuss the Company’s fourth quarter of fiscal 2019 results. To participate, please dial +1 (844) 513-7152, or +1 (508) 637-5600 outside the United States, approximately 15 minutes before the call and enter passcode 7084814. The call will also be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These non-GAAP measures exclude the following items:

 

   

amortization of purchased intangible assets and other acquisition-related costs;

 

   

changes in certain acquisition-related liabilities measured at fair value;

 

   

non-recurring and unusual charges;


   

equity-based compensation expense;

 

   

other; and

 

   

tax effects related to the above.

Free cash flow equals cash generated by operating activities less net capital expenditures and other, and normalized free cash flow is adjusted to exclude net capital expenditures related to the new campus development, payments for previously expensed restructuring charges, payments for legal dispute settlement, and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased


intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, non-recurring and unusual charges, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

 

   

Keep up with Amdocs news by visiting the Company’s website

 

   

Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and YouTube

About Amdocs

Amdocs is a leading software and services provider to communications and media companies of all sizes, accelerating the industry’s dynamic and continuous digital transformation. With a rich set of innovative solutions, long-term business relationships with 350 communications and media providers, and technology and distribution ties to 600 content creators, Amdocs delivers business improvements to drive growth. Amdocs and its 25,000 employees serve customers in over 85 countries. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.1 billion in fiscal 2019.


For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2018 filed on December 10, 2018 and our Form 6-K furnished for the first quarter of fiscal 2019 on February 19, 2019 and for the second quarter of fiscal 2019 on May 28, 2019 and for the third quarter of fiscal 2019 on August 19, 2019.

Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com


AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)

 

     Three months ended     Fiscal year ended  
     September 30,     September 30,  
     2019      2018     2019     2018  

Revenue

   $ 1,030,253      $ 1,002,588     $ 4,086,669     $ 3,974,837  

Operating expenses:

         

Cost of revenue

     667,129        654,923       2,653,172       2,595,276  

Research and development

     70,109        70,783       273,936       276,615  

Selling, general and administrative

     125,046        125,830       492,457       481,093  

Amortization of purchased intangible assets and other

     23,815        27,233       97,358       108,489  

Non-recurring charges

     —          55,000       —         85,057  
  

 

 

    

 

 

   

 

 

   

 

 

 
     886,099        933,769       3,516,923       3,546,530  
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating income

     144,154        68,819       569,746       428,307  

Interest and other income (expense), net

     2,444        (3,436     (1,859     (6,766
  

 

 

    

 

 

   

 

 

   

 

 

 

Income before income taxes

     146,598        65,383       567,887       421,541  

Income taxes

     24,571        21,117       88,441       67,145  
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income

   $ 122,027      $ 44,266     $ 479,446     $ 354,396  
  

 

 

    

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 0.90      $ 0.31     $ 3.49     $ 2.49  
  

 

 

    

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 0.90      $ 0.31     $ 3.47     $ 2.47  
  

 

 

    

 

 

   

 

 

   

 

 

 

Basic weighted average number of shares outstanding

     135,317        140,760       137,418       142,422  
  

 

 

    

 

 

   

 

 

   

 

 

 

Diluted weighted average number of shares outstanding

     136,151        141,872       138,108       143,703  
  

 

 

    

 

 

   

 

 

   

 

 

 

Cash dividends declared per share

   $ 0.285      $ 0.250     $ 1.105     $ 0.970  
  

 

 

    

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Selected Financial Metrics

(In thousands, except per share data)

 

     Three months ended      Fiscal year ended  
     September 30,      September 30,  
     2019      2018      2019      2018  

Revenue

   $ 1,030,253      $ 1,002,588      $ 4,086,669      $ 3,974,837  

Non-GAAP operating income

     177,989        172,606        707,889        687,020  

Non-GAAP net income

     147,137        140,230        595,089        579,593  

Non-GAAP diluted earnings per share

   $ 1.08      $ 0.99      $ 4.31      $ 4.03  

Diluted weighted average number of shares outstanding

     136,151        141,872        138,108        143,703  

Free Cash Flows and Normalized Free Cash Flow

(In thousands)

 

     Three months ended     Fiscal year ended  
     September 30,     September 30,  
     2019     2018     2019     2018  

Net Cash Provided by Operating Activities

   $ 213,625     $ 115,349     $ 656,377     $ 557,249  

Purchases of property and equipment, net (*)

     (34,325     (33,893     (128,086     (231,146

Other

     —         (135     —         (458
  

 

 

   

 

 

   

 

 

   

 

 

 

Free Cash Flow

     179,300       81,321       528,291       325,645  

Payments for legal dispute settlement

     —         —         55,000       —    

Payments for previously expensed restructuring charges

     1,233       6,500       15,627       6,500  

Net capital expenditures related to the new campus development (*)

     9,101       1,218       6,895       96,229  

Payments of acquisition related liabilities

     —         —         7,667       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Normalized Free Cash Flow

   $ 189,634     $ 89,039     $ 613,480     $ 428,374  
  

 

 

   

 

 

   

 

 

   

 

 

 

(*) The amounts under “Purchase of property and equipment, net”, and the amounts under “Net capital expenditures related to the new campus development” include proceeds of $9,676 relating to the refund of betterment levy for fiscal year ended 30 September 2019 and proceeds from sale of property and equipment of $77 and $151, $346 and $459, for the three months and fiscal year ended 30 September 2019 and 2018, respectively.


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Three months ended
September 30, 2019
 
            Reconciliation items        
     GAAP      Amortization of
purchased
intangible assets
and other
    Equity-based
compensation
expense
    Changes in certain
acquisition related
liabilities
measured at fair
value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

               

Cost of revenue

   $ 667,129      $ —       $ (4,618   $ (2,036   $ —       $ —       $ 660,475  

Research and development

     70,109        —         (757     —         —         —         69,352  

Selling, general and administrative

     125,046        —         (2,609     —         —         —         122,437  

Amortization of purchased intangible assets and other

     23,815        (23,815     —         —         —         —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     886,099        (23,815     (7,984     (2,036     —         —         852,264  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     144,154        23,815       7,984       2,036       —         —         177,989  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other income (expense), net

     2,444        —         —         —         (4,964     —         (2,520
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     24,571        —         —         —         —         3,761       28,332  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 122,027      $ 23,815     $ 7,984     $ 2,036     $ (4,964   $ (3,761   $ 147,137  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     Three months ended
September 30, 2018
 
            Reconciliation items        
     GAAP      Amortization of
purchased
intangible assets
and other
    Equity-based
compensation
expense
    Changes in certain
acquisitions
related liabilities
measured at fair
value
    Non-recurring
charges
    Tax
effect
    Non-GAAP  

Operating expenses:

               

Cost of revenue

   $ 654,923      $ —       $ (3,752   $ (8,658   $ —       $ —       $ 642,513  

Research and development

     70,783        —         (813     —         —         —         69,970  

Selling, general and administrative

     125,830        —         (8,331     —         —         —         117,499  

Amortization of purchased intangible assets and other

     27,233        (27,233     —         —         —         —         —    

Non-recurring charges

     55,000        —         —         —         (55,000     —         —    
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     933,769        (27,233     (12,896     (8,658     (55,000     —         829,982  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     68,819        27,233       12,896       8,658       55,000       —         172,606  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     21,117        —         —         —         —         7,822       28,940  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 44,266      $ 27,233     $ 12,896     $ 8,658     $ 55,000     $ (7,822   $ 140,230  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

 

     Fiscal year ended
September 30, 2019
 
           Reconciliation items        
     GAAP     Amortization of
purchased
intangible assets
and other
    Equity-based
compensation
expense
    Changes in certain
acquisition related
liabilities
measured at fair
value
    Other     Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 2,653,172     $ —       $ (19,879   $ (2,235   $ —       $ —       $ 2,631,058  

Research and development

     273,936       —         (2,714     —         —         —         271,222  

Selling, general and administrative

     492,457       —         (15,957     —         —         —         476,500  

Amortization of purchased intangible assets and other

     97,358       (97,358     —         —         —         —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     3,516,923       (97,358     (38,550     (2,235     —         —         3,378,780  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     569,746       97,358       38,550       2,235       —         —         707,889  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other income (expense), net

     (1,859     —         —         —         (2,939     —         (4,798
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     88,441       —         —         —         —         19,561       108,002  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 479,446     $ 97,358     $ 38,550     $ 2,235     $ (2,939   $ (19,561   $ 595,089  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     Fiscal year ended
September 30, 2018
 
           Reconciliation items        
     GAAP     Amortization of
purchased
intangible assets
and other
    Equity-based
compensation
expense
    Changes in certain
acquisitions
related liabilities
measured at fair
value
    Non-recurring
charges
    Tax
effect
    Non-GAAP  

Operating expenses:

              

Cost of revenue

   $ 2,595,276     $ —       $ (18,253   $ (17,692   $ —       $ —       $ 2,559,331  

Research and development

     276,615       —         (3,477     —         —         —         273,138  

Selling, general and administrative

     481,093       —         (25,746     —         —         —         455,347  

Amortization of purchased intangible assets and other

     108,489       (108,489     —         —         —         —         —    

Non-recurring charges

     85,057       —         —         —         (85,057     —         —    
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     3,546,530       (108,489     (47,476     (17,692     (85,057     —         3,287,816  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     428,307       108,489       47,476       17,692       85,057       —         687,020  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     67,145       —         —         —         —         33,517       100,662  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 354,396     $ 108,489     $ 47,476     $ 17,692     $ 85,057     $ (33,517   $ 579,593  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(In thousands)

 

     As of  
     September 30,
2019
     September 30,
2018
 

ASSETS

     

Current assets

     

Cash, cash equivalents and short-term interest-bearing investments

   $ 471,632      $ 519,216  

Accounts receivable, net, including unbilled of $227,061 and $263,997, respectively

     987,858        971,502  

Prepaid expenses and other current assets

     216,084        229,999  
  

 

 

    

 

 

 

Total current assets

     1,675,574        1,720,717  

Property and equipment, net

     525,314        496,585  

Goodwill and other intangible assets, net

     2,667,997        2,710,144  

Other noncurrent assets

     423,941        420,369  
  

 

 

    

 

 

 

Total assets

   $ 5,292,826      $ 5,347,815  
  

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current liabilities

     

Accounts payable, accruals and other

   $ 1,089,748      $ 1,162,543  

Deferred revenue

     118,182        132,414  
  

 

 

    

 

 

 

Total current liabilities

     1,207,930        1,294,957  

Other noncurrent liabilities

     542,430        560,816  

Total Amdocs Limited Shareholders’ equity

     3,499,957        3,448,879  

Noncontrolling interests

     42,509        43,163  
  

 

 

    

 

 

 

Total equity

     3,542,466        3,492,042  
  

 

 

    

 

 

 

Total liabilities and equity

   $ 5,292,826      $ 5,347,815  
  

 

 

    

 

 

 


AMDOCS LIMITED

Consolidated Statements of Cash Flows

(In thousands)

 

     Fiscal year ended
September 30,
 
     2019     2018  

Cash Flow from Operating Activities:

    

Net income

   $ 479,446     $ 354,396  

Reconciliation of net income to net cash provided by operating activities:

    

Depreciation and amortization

     205,772       211,224  

Equity-based compensation expense

     38,550       47,476  

Deferred income taxes

     (13,950     25,098  

Loss from short-term interest-bearing investments

     737       1,324  

Net changes in operating assets and liabilities, net of amounts acquired:

    

Accounts receivable, net

     6,589       (66,451

Prepaid expenses and other current assets

     25,907       (18,736

Other noncurrent assets

     (1,635     9,674  

Accounts payable, accrued expenses and accrued personnel

     (60,042     25,348  

Deferred revenue

     (37,855     7,650  

Income taxes payable, net

     6,025       (31,036

Other noncurrent liabilities

     6,833       (8,718
  

 

 

   

 

 

 

Net cash provided by operating activities

     656,377       557,249  
  

 

 

   

 

 

 

Cash Flow from Investing Activities:

    

Purchases of property and equipment, net (*)

     (128,086     (231,146

Proceeds from sale of short-term interest-bearing investments

     101,287       303,090  

Purchase of short-term interest-bearing investments

     —         (76,037

Net cash paid for acquisitions

     (60,572     (355,142

Other

     615       (3,157
  

 

 

   

 

 

 

Net cash used in investing activities

     (86,756     (362,392
  

 

 

   

 

 

 

Cash Flow from Financing Activities:

    

Borrowings under financing arrangements

     —         120,000  

Payments under financing arrangements

     —         (120,000

Repurchase of shares

     (398,057     (419,228

Proceeds from employee stock options exercised

     41,483       81,280  

Payments of dividends

     (147,616     (134,292

Investment by noncontrolling interests, net

     (4,776     47,013  

Payment of contingent consideration from a business acquisition

     (7,470     —    

Other

     (336     (458
  

 

 

   

 

 

 

Net cash used in financing activities

     (516,772     (425,685
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     52,849       (230,828

Cash and cash equivalents at beginning of period

     418,783       649,611  
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 471,632     $ 418,873  
  

 

 

   

 

 

 

 

 

(*) The amounts under “Purchase of property and equipment, net”, include proceeds of $9,676 relating to the refund of betterment levy for the fiscal year ended September 30, 2019 and proceeds from sale of property and equipment of $151 and $459, for the fiscal year ended September 30, 2019 and 2018, respectively.


AMDOCS LIMITED

Supplementary Information

(In millions)

 

     Three months ended  
     September 30,
2019
     June 30,
2019
     March 31,
2019
     December 31,
2018
     September 30,
2018
 

North America

   $ 644.2      $ 643.9      $ 634.2      $ 660.5      $ 638.2  

Europe

     156.1        145.5        151.0        146.1        150.6  

Rest of the World

     230.0        235.3        234.5        205.5        213.8  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 1,030.3      $ 1,024.7      $ 1,019.7      $ 1,012.1      $ 1,002.6  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended  
     September 30,
2019
     June 30,
2019
     March 31,
2019
     December 31,
2018
     September 30,
2018
 

Managed Services Revenue

   $ 583.3      $ 578.1      $ 559.5      $ 525.5      $ 508.9  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     As of  
     September 30,
2019
     June 30,
2019
     March 31,
2019
     December 31,
2018
     September 30,
2018
 

12-Month Backlog

   $ 3,490      $ 3,400      $ 3,390      $ 3,370      $ 3,360  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

# # #